{
    "id": 28512,
    "fullName": "EGFR N771delinsFH",
    "impact": "indel",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "EGFR N771delinsFH results in a deletion of asparagine (N) at amino acid 771 within the protein kinase domain of the Egfr protein, combined with the insertion of a phenylalanine (F) and a histidine (H) at the same site (UniProt.org). N771delinsFH has not been biochemically characterized, but is predicted to result in a gain of function based on the effect of other Egfr exon 20 insertions (PMID: 24353160).",
            "references": [
                {
                    "id": 440,
                    "pubMedId": 24353160,
                    "title": "Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24353160"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "N771delinsFH",
    "createDate": "07/25/2018",
    "updateDate": "02/11/2019",
    "referenceTranscriptCoordinates": {
        "id": 178320,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55181320_55181322delinsTTTCAT",
        "cDna": "c.2311_2313delinsTTTCAT",
        "protein": "p.N771_771delinsFH",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 14846,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Poziotinib (HM781-36B) growth of a lung adenocarcinoma patient-derived cell line harboring EGFR N771delinsFH in culture, and decreased tumor burden in xenograft models (PMID: 29686424).",
            "molecularProfile": {
                "id": 30377,
                "profileName": "EGFR N771delinsFH"
            },
            "therapy": {
                "id": 1042,
                "therapyName": "Poziotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 11486,
                    "pubMedId": 29686424,
                    "title": "Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29686424"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30377,
            "profileName": "EGFR N771delinsFH",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 178320,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55181320_55181322delinsTTTCAT",
            "cDna": "c.2311_2313delinsTTTCAT",
            "protein": "p.N771_771delinsFH",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}